Norman E. Sládek
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
-
- Chemotherapy-induced organ toxicity mitigation
- Alcohol Consumption and Health Effects
Papers in
-
- Genomics, phytochemicals, and oxidative stress 18
-
- Alcohol Consumption and Health Effects 12
- Chemotherapy-induced organ toxicity mitigation 9
- Co-authors
- Gilbert J. Mannering (6 shared papers)Lakshmaiah Sreerama (20 shared papers)Mi‐Ock Lee (4 shared papers)Carl L. Manthey (6 shared papers)Bruce E. Domeyer (4 shared papers)David T. Kiang (1 shared paper)Rahn Kollander (1 shared paper)Ursula C. Dräger (1 shared paper)
- Journals
- Biochemical Pharmacology (16 papers)Advances in experimental medicine and biology (7 papers)Chemico-Biological Interactions (5 papers)Drug Metabolism and Disposition (5 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)
- Partner nations
- United States
In The Last Decade
Norman E. Sládek
80 papers receiving 3.6k citations
Norman E. Sládek's Hit Papers
Peers
Comparison fields: 5 of 112
- Pharmacology 905
- Pathology and Forensic Medicine 874
- Cancer Research 728
- Biochemistry 270
- Oncology 810
Countries citing papers authored by Norman E. Sládek
This map shows the geographic impact of Norman E. Sládek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman E. Sládek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman E. Sládek more than expected).
Fields of papers citing papers by Norman E. Sládek
This network shows the impact of papers produced by Norman E. Sládek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman E. Sládek. The network helps show where Norman E. Sládek may publish in the future.
Co-authors
The 25 scholars most cited alongside Norman E. Sládek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evidence for a new P-450 hemoprotein in hepatic microsomes from methylcholanthrene treated rats Hit paper breakdown → | 1966 | 353 |
| 2 | 1988 | 268 | |
| 3 | 2003 | 213 | |
| 4 | 1992 | 200 | |
| 5 | 2002 | 168 | |
| 6 | Induction of drug metabolism. I. Differences in the mechanisms by which polycyclic hydrocarbons and phenobarbital produce their inductive effects on microsomal N-demethylating systems. | 1969 | 165 |
| 7 | 1992 | 133 | |
| 8 | 1991 | 131 | |
| 9 | Therapeutic efficacy of cyclophosphamide as a function of its metabolism. | 1972 | 97 |
| 10 | Induction of drug metabolism. II. Qualitative differences in the microsomal N-demethylating systems stimulated by polycyclic hydrocarbons and by phenobarbital. | 1969 | 93 |
| 11 | 1999 | 87 | |
| 12 | Kinetics of cyclophosphamide biotransformation in vivo. | 1980 | 87 |
| 13 | Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli. | 1995 | 86 |
| 14 | Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines. | 1985 | 75 |
| 15 | 1993 | 74 | |
| 16 | Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo. | 1973 | 69 |
| 17 | Identification of the mouse aldehyde dehydrogenases important in aldophosphamide detoxification. | 1990 | 67 |
| 18 | Evidence for an aldehyde possessing alkylating activity as the primary metabolite of cyclophosphamide. | 1973 | 64 |
| 19 | 1989 | 60 | |
| 20 | Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis. | 1982 | 58 |
About Norman E. Sládek
Norman E. Sládek is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Cancer Research, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health, having authored 80 papers that have together received 3.7k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (18 papers), Acute Lymphoblastic Leukemia research (12 papers), Alcohol Consumption and Health Effects (12 papers), Chemotherapy-induced organ toxicity mitigation (9 papers), Carcinogens and Genotoxicity Assessment (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). The work is most often cited by research in Pharmacology (905 citations), Pathology and Forensic Medicine (874 citations), Cancer Research (728 citations), Biochemistry (270 citations) and Oncology (810 citations). Norman E. Sládek has collaborated with scholars based in United States. Frequent co-authors include Gilbert J. Mannering, Lakshmaiah Sreerama, Mi‐Ock Lee, Carl L. Manthey, Bruce E. Domeyer, David T. Kiang, Rahn Kollander, Ursula C. Dräger, Peter McCaffery and Michael Wagner. Their work appears in journals such as Biochemical Pharmacology, Advances in experimental medicine and biology, Chemico-Biological Interactions, Drug Metabolism and Disposition and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.